Explore our latest innovations and publications and discover how we leverage human iPSC technology to catalyze drug discovery.
The status of drug discovery and development for Parkinson's disease
Uncovering ALS pathology and potential drug targets with in vitro iPSC models
The status of drug discovery and development for Alzheimer's disease
Case Study: Modeling Friedreich’s ataxia using patient-derived iPSCs
White paper: Advancing drug discovery for neurodegenerative diseases
Case Study: A model of Alzheimer’s disease